Catechol

Catechol

SCHEMBL822172

Oc1ccc(O)c(O)c1.Oc1ccccc1O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.59
ALDH1A1 P00352 2/20 0.59
CA2 P00918 2/20 0.59
LMNA P02545 2/20 0.59
CYP3A4 P08684 2/20 0.59
CA5A P35218 2/20 0.59
HSD17B10 Q99714 2/20 0.59
CA14 Q9ULX7 2/20 0.59
CA5B Q9Y2D0 2/20 0.59
KDM4E B2RXH2 1/20 0.59
NPC1 O15118 1/20 0.59
GMNN O75496 1/20 0.59
EGFR P00533 1/20 0.59
FYN P06241 1/20 0.59
POLB P06746 1/20 0.59
CA3 P07451 1/20 0.59
MAPT P10636 1/20 0.59
MMP9 P14780 1/20 0.59
HPGD P15428 1/20 0.59
ALOX15 P16050 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL21834592 0.91 ALOX5 (0.56) CA12ALDH1A1CA2LMNACYP3A4
SCHEMBL33527 0.91
SCHEMBL29829218 0.91
SCHEMBL4862349 0.91 ALOX5 (0.60) CA12ALDH1A1CA2LMNAHSD17B10
Pyrogallol SCHEMBL27863303 0.90 ALDH1A1 (0.57) CA12ALDH1A1CA2LMNACYP3A4
Phenol SCHEMBL4387959 0.89 CA12 (0.58) CA12ALDH1A1CA2LMNACYP3A4
SCHEMBL6676690 0.88 ALOX5 (0.57) CA12ALDH1A1CA2LMNAHSD17B10
SCHEMBL31122728 0.88 ALOX5 (0.57) CA12ALDH1A1CA2LMNAHSD17B10
Hydrogen Sulfide SCHEMBL11691776 0.88 ALOX5 (0.57) CA12ALDH1A1CA2LMNAHSD17B10
Phosphine SCHEMBL11514630 0.88 ALOX5 (0.57) CA12ALDH1A1CA2LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110287067-A1 REINFORCED ADHESIVE COMPLEX COACERVATES AND METHODS OF MAKING AND USING THEREOF UNIVERSITY OF UTAH RESEARCH FOUNDATION 2011-11-24 US disclosed
WO-2011106595-A1 ADHESIVE COMPLEX COACERVATES PRODUCED FROM ELECTROSTATICALLY ASSOCIATED BLOCK COPOLYMERS AND METHODS FOR MAKING AND USING THE SAME UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2011-09-01 WO disclosed
US-20080050398-A1 Composition Comprising Beta-Defensin 2 HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110287067-A1 REINFORCED ADHESIVE COMPLEX COACERVATES AND METHODS OF MAKING AND USING THEREOF COL14A1, COL2A1, PUF60 CA12 655/4885ALDH1A1 2397/4885CA2 2199/4885
US-20080050398-A1 Composition Comprising Beta-Defensin 2 DLK1, DSG1, DBNL CA12 2249/4885ALDH1A1 2395/4885CA2 3073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.